Compare Orchid Chemicals with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs FULFORD INDIA - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD FULFORD INDIA ORCHID PHARMA LTD/
FULFORD INDIA
 
P/E (TTM) x -0.5 398.8 - View Chart
P/BV x 0.1 6.2 1.9% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 ORCHID PHARMA LTD   FULFORD INDIA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
FULFORD INDIA
Mar-14
ORCHID PHARMA LTD/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs194942 20.6%   
Low Rs35450 7.8%   
Sales per share (Unadj.) Rs276.5691.4 40.0%  
Earnings per share (Unadj.) Rs-79.211.5 -691.1%  
Cash flow per share (Unadj.) Rs-43.515.4 -282.9%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.3 0.0%  
Book value per share (Unadj.) Rs53.9380.0 14.2%  
Shares outstanding (eoy) m70.453.90 1,806.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.41.0 41.1%   
Avg P/E ratio x-1.460.7 -2.4%  
P/CF ratio (eoy) x-2.645.3 -5.8%  
Price / Book Value ratio x2.11.8 115.9%  
Dividend payout %017.4 0.0%   
Avg Mkt Cap Rs m8,0672,714 297.2%   
No. of employees `0002.80.4 630.6%   
Total wages/salary Rs m2,527505 500.4%   
Avg. sales/employee Rs Th6,956.16,073.0 114.5%   
Avg. wages/employee Rs Th902.51,137.4 79.3%   
Avg. net profit/employee Rs Th-1,993.0100.7 -1,979.6%   
INCOME DATA
Net Sales Rs m19,4772,696 722.3%  
Other income Rs m407125 324.7%   
Total revenues Rs m19,8842,822 704.7%   
Gross profit Rs m1,103-46 -2,376.3%  
Depreciation Rs m2,51915 16,573.7%   
Interest Rs m5,22710 55,018.9%   
Profit before tax Rs m-6,23654 -11,484.7%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-12510 -1,304.2%   
Profit after tax Rs m-5,58045 -12,483.9%  
Gross profit margin %5.7-1.7 -329.0%  
Effective tax rate %2.017.7 11.4%   
Net profit margin %-28.71.7 -1,728.3%  
BALANCE SHEET DATA
Current assets Rs m11,0141,738 633.6%   
Current liabilities Rs m32,060545 5,885.9%   
Net working cap to sales %-108.144.3 -244.1%  
Current ratio x0.33.2 10.8%  
Inventory Days Days9548 195.8%  
Debtors Days Days344 779.5%  
Net fixed assets Rs m29,44012 247,394.1%   
Share capital Rs m70539 1,806.4%   
"Free" reserves Rs m2,0431,443 141.6%   
Net worth Rs m3,8001,482 256.4%   
Long term debt Rs m9,0180-   
Total assets Rs m46,5102,077 2,239.6%  
Interest coverage x-0.26.7 -2.9%   
Debt to equity ratio x2.40-  
Sales to assets ratio x0.41.3 32.3%   
Return on assets %-0.82.6 -29.1%  
Return on equity %-146.93.0 -4,868.8%  
Return on capital %-3.74.3 -86.8%  
Exports to sales %37.90-   
Imports to sales %22.624.5 92.5%   
Exports (fob) Rs m7,378NA-   
Imports (cif) Rs m4,406659 668.3%   
Fx inflow Rs m7,51317 43,682.0%   
Fx outflow Rs m5,649673 839.1%   
Net fx Rs m1,865-656 -284.2%   
CASH FLOW
From Operations Rs m1,68290 1,868.6%  
From Investments Rs m-9,860105 -9,426.8%  
From Financial Activity Rs m6,644-14 -47,119.1%  
Net Cashflow Rs m-1,535181 -850.4%  

Share Holding

Indian Promoters % 32.3 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.6 3.8 121.1%  
FIIs % 3.3 0.1 3,300.0%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 21.2 260.8%  
Shareholders   84,811 4,783 1,773.2%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   DR. DATSONS LABS  DISHMAN PHARMA  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Jumps 350 Points; Tata Motors and Vedanta Top Gainers(12:30 pm)

Share markets in India are presently trading on a strong note. Benchmark indices opened higher today tracking global markets on renewed optimism about a US-China trade deal.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - IPCA LABS COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS